中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
中国医药(600056) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入2,979,676.752,162,497.121,253,066.323,759,264.952,691,723.00
营业收入2,979,676.752,162,497.121,253,066.323,759,264.952,691,723.00
二、营业总成本2,868,495.192,072,080.251,209,366.863,613,794.052,579,065.55
营业成本2,649,590.261,922,111.881,129,749.203,284,578.592,347,550.15
营业税金及附加9,563.956,753.403,238.0811,529.728,599.74
销售费用121,001.3786,818.8946,335.14195,051.16137,763.39
管理费用74,269.0548,644.1123,002.63101,070.0168,086.82
财务费用6,722.952,384.874,324.1513,831.6712,166.47
研发费用7,347.625,367.092,717.677,732.904,898.98
资产减值损失----------
公允价值变动收益33.433.2782.78192.23-35.58
投资收益2,781.843,140.761,530.305,100.105,059.58
其中:对联营企业和合营企业的投资收益6,571.375,774.872,087.379,321.909,157.69
汇兑收益----------
三、营业利润110,548.8987,314.2940,684.49119,969.80122,875.04
加:营业外收入1,469.64745.6921.171,491.081,553.43
减:营业外支出1,103.48629.9144.621,848.17902.87
其中:非流动资产处置损失----------
四、利润总额110,915.0587,430.0640,661.03119,612.70123,525.60
减:所得税费用32,548.7719,754.738,602.8030,815.8829,720.01
五、净利润78,366.2867,675.3332,058.2388,796.8293,805.59
归属于母公司所有者的净利润59,411.0654,354.7726,877.0173,570.5276,671.37
少数股东损益18,955.2213,320.575,181.2215,226.3017,134.22
六、每股收益
基本每股收益(元/股)0.39720.36340.17970.49180.5126
稀释每股收益(元/股)0.39720.36340.17970.49180.5126
七、其他综合收益70.66161.9322.55805.92-69.80
八、综合收益总额78,436.9467,837.2632,080.7989,602.7493,735.79
归属于母公司所有者的综合收益总额59,481.7254,516.6926,899.5774,420.4676,601.57
归属于少数股东的综合收益总额18,955.2213,320.575,181.2215,182.2817,134.22
下载全部历史数据到excel中 返回页顶